🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial studies fludarabine phosphate, low-dose total body irra...
Status
Completed
Location
City of Hope Medical Center
Start Date
1999-11
Trial ID
NCT00005799
Treatments Being Tested
This trial is designed to expand the currently available data on the safety...
Status
Completed
Location
ECOGENE-21 Clinical Trial Center / Centre de santé et de services sociaux de Chicoutimi
Start Date
2009-02
Trial ID
NCT00891306
This study compares haplo-identical family donor stem cell transplantation ...
Status
Terminated
Location
Medical University of Vienna
Start Date
2019-11-12
Trial ID
NCT04067180
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Terminated
Location
Rocky Mountain Cancer Centers
Start Date
2001-10
Trial ID
NCT00041288
Following a transplant for hepatitis C cirrhosis, the infection comes back ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2006-01
Trial ID
NCT00260208
Treatments Being Tested
Giving chemotherapy drugs, such as fludarabine and busulfan, before a donor...
Status
Completed
Location
University of California Davis Cancer Center
Start Date
2007-06
Trial ID
NCT00619645
This study will investigate the efficacy and safety of a steroid avoidance ...
Status
Completed
Location
C.H.U. La Milétrie
Start Date
2007-04
Trial ID
NCT00413920
Treatments Being Tested
The purpose of this study is to determine the response and toxicity rate of...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2022-01-01
Trial ID
NCT05166967
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of the current t...
Status
Unknown
Location
The Second Xiangya Hospital, Central South University
Start Date
2018-12-01
Trial ID
NCT03791827
RATIONALE: - Relapsed or refractory Neuroblastoma (NBL) carries a very poor...
Status
Withdrawn
Location
Children's Memorial Hospital
Start Date
2008-09
Trial ID
NCT00874315